Viewing Study NCT05872204


Ignite Creation Date: 2025-12-24 @ 8:02 PM
Ignite Modification Date: 2025-12-30 @ 5:44 PM
Study NCT ID: NCT05872204
Status: RECRUITING
Last Update Posted: 2025-03-19
First Post: 2023-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Sponsor: Universitaire Ziekenhuizen KU Leuven
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Low Grade Serous Ovarian Carcinoma View
None Adult Type Granulosa Cell Tumor View
Keywords: